Gene Expression Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Gene Expression Market, By Process Type

7.1.  Gene Expression Market, by Process Type, 2020-2030

7.1.1.    Sample Collection

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Purification

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    cDNA Synthesis & Conversion

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    PCR Analysis

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Data Analysis & Interpretation

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Gene Expression Market, By Product Type

8.1.  Gene Expression Market, by Product Type, 2020-2030

8.1.1.    Kits & Reagents

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    DNA Chip/Microarray

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Gene Expression Market, By Capacity Type

9.1.  Gene Expression Market, by Capacity Type, 2020-2030

9.1.1.    Low- to Mid-Plex

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    High-Plex

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Gene Expression Market, By Technique Type  

10.1.        Gene Expression Market, by Technique Type , 2020-2030

10.1.1.  RNA Exp.

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Promoter Analysis

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Protein Exp. & Posttranslational Modification Analysis

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Gene Expression Market, By Application Type

11.1.        Gene Expression Market, by Application Type, 2020-2030

11.1.1.  Drug Discovery & Development

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Clinical Diagnostics

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Biotechnology & Microbiology

11.1.3.1.      Market Revenue and Forecast (2016-2030)

11.1.4.  Others

11.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Gene Expression  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Process Type (2016-2030)

12.1.2.  Market Revenue and Forecast, by Product Type (2016-2030)

12.1.3.  Market Revenue and Forecast, by Capacity Type (2016-2030)

12.1.4.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.1.5.  Market Revenue and Forecast, by Application Type (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.1.6.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.1.6.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.1.6.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.1.7.  Market Revenue and Forecast, by Application Type (2016-2030)

12.1.8.  Rest of North America

12.1.8.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.1.8.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.1.8.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.1.8.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.1.8.5.      Market Revenue and Forecast, by Application Type (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Process Type (2016-2030)

12.2.2.  Market Revenue and Forecast, by Product Type (2016-2030)

12.2.3.  Market Revenue and Forecast, by Capacity Type (2016-2030)

12.2.4.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.2.5.  Market Revenue and Forecast, by Application Type (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.2.6.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.2.6.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.2.7.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.2.8.  Market Revenue and Forecast, by Application Type (2016-2030)

12.2.9.  Germany

12.2.9.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.2.9.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.2.9.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.2.10.               Market Revenue and Forecast, by Technique Type  (2016-2030)

12.2.11.               Market Revenue and Forecast, by Application Type (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.2.12.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.2.12.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.2.12.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.2.13.               Market Revenue and Forecast, by Application Type (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.2.14.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.2.14.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.2.14.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.2.15.               Market Revenue and Forecast, by Application Type (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Process Type (2016-2030)

12.3.2.  Market Revenue and Forecast, by Product Type (2016-2030)

12.3.3.  Market Revenue and Forecast, by Capacity Type (2016-2030)

12.3.4.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.3.5.  Market Revenue and Forecast, by Application Type (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.3.6.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.3.6.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.3.6.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.3.7.  Market Revenue and Forecast, by Application Type (2016-2030)

12.3.8.  China

12.3.8.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.3.8.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.3.8.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.3.8.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.3.9.  Market Revenue and Forecast, by Application Type (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.3.10.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.3.10.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.3.10.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.3.10.5.   Market Revenue and Forecast, by Application Type (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.3.11.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.3.11.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.3.11.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.3.11.5.   Market Revenue and Forecast, by Application Type (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Process Type (2016-2030)

12.4.2.  Market Revenue and Forecast, by Product Type (2016-2030)

12.4.3.  Market Revenue and Forecast, by Capacity Type (2016-2030)

12.4.4.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.4.5.  Market Revenue and Forecast, by Application Type (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.4.6.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.4.6.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.4.6.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.4.7.  Market Revenue and Forecast, by Application Type (2016-2030)

12.4.8.  North Africa

12.4.8.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.4.8.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.4.8.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.4.8.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.4.9.  Market Revenue and Forecast, by Application Type (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.4.10.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.4.10.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.4.10.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.4.10.5.   Market Revenue and Forecast, by Application Type (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, by Process Type (2016-2030)

12.4.11.2.   Market Revenue and Forecast, by Product Type (2016-2030)

12.4.11.3.   Market Revenue and Forecast, by Capacity Type (2016-2030)

12.4.11.4.   Market Revenue and Forecast, by Technique Type  (2016-2030)

12.4.11.5.   Market Revenue and Forecast, by Application Type (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Process Type (2016-2030)

12.5.2.  Market Revenue and Forecast, by Product Type (2016-2030)

12.5.3.  Market Revenue and Forecast, by Capacity Type (2016-2030)

12.5.4.  Market Revenue and Forecast, by Technique Type  (2016-2030)

12.5.5.  Market Revenue and Forecast, by Application Type (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.5.6.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.5.6.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.5.6.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.5.7.  Market Revenue and Forecast, by Application Type (2016-2030)

12.5.8.  Rest of LATAM

12.5.8.1.      Market Revenue and Forecast, by Process Type (2016-2030)

12.5.8.2.      Market Revenue and Forecast, by Product Type (2016-2030)

12.5.8.3.      Market Revenue and Forecast, by Capacity Type (2016-2030)

12.5.8.4.      Market Revenue and Forecast, by Technique Type  (2016-2030)

12.5.8.5.      Market Revenue and Forecast, by Application Type (2016-2030)

Chapter 13.  Company Profiles

13.1.              QIAGEN

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Quest Diagnostics, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              F. Hoffmann-La Roche Ltd.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Illumina, Inc.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              PerkinElmer, Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Bio-Rad Laboratories

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Thermo Fisher Scientific, Inc.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Agilent Technologies

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              GE Healthcare

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Promega Corp.

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Luminex Corp.

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Takara Bio, Inc.

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           Danaher Corp.

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

13.14.           ELITechGroup

13.14.1.               Company Overview

13.14.2.               Product Offerings

13.14.3.               Financial Performance

13.14.4.               Recent Initiatives

13.15.           AutoGenomics

13.15.1.               Company Overview

13.15.2.               Product Offerings

13.15.3.               Financial Performance

13.16.           Biocartis NV

13.16.1.               Company Overview

13.16.2.               Product Offerings

13.16.3.               Financial Performance

13.17.           IntegraGen

13.17.1.               Company Overview

13.17.2.               Product Offerings

13.17.3.               Financial Performance

13.18.           Interpace Biosciences, Inc.

13.18.1.               Company Overview

13.18.2.               Product Offerings

13.18.3.               Financial Performance

13.19.           Fluidigm Corp.

13.19.1.               Company Overview

13.19.2.               Product Offerings

13.19.3.               Financial Performance

13.19.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms